SKIN: the cashflow

MyFinsight

The latest financial statement is for the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-11,031	9,616
Share-based compensation	2,455	8,784
Amortization of intangible assets	6,712	6,801
Depreciation of property and equipment	637	2,567
Amortization of other assets	1,084	2,197
Amortization of debt issuance costs	981	1,640
Inventory write-down	1,165	2,478
Provision for estimated credit losses	356	1,577
Change in fair value of warrant liabilities	-210	-139
Gain on exchange and repurchases of convertible senior notes, net	0	18,089
Deferred income taxes	2,075	818
Other, net	1,319	-3,998
Accounts receivable	-2,488	-2,281
Inventories	-2,025	-9,089
Prepaid expenses, other current assets, and income tax receivable	678	-568
Accounts payable, accrued expenses, and income tax payable	2,604	-9,721
Other, net	2,335	3,827
Net cash provided by (used for) operating activities	9,647	12,642
Cash paid for intangible assets	1,057	2,560
Cash paid for property and equipment	27	137
Net cash used for investing activities	-1,084	-2,697
Repurchase of 2026 notes in connection with exchange	0	392,583
Issuance of 2028 notes in connection with exchange, net	-616	238,302
Repurchase of 2026 notes	0	18,372
Payment of tax withholdings on vested stock awards	187	958
Net cash used for financing activities	-803	-173,611
Net change in cash, cash equivalents, and restricted cash	7,760	-163,666
Effect of exchange rate changes on cash	5,240	-
Cash and cash equivalents at beginning of period	370,063	-
Cash and cash equivalents at end of period	219,397	-

Unit: Thousand (K) dollars